Photo by sammoqadam from unsplash
N‐Acetylcysteine (NAC), an antioxidative reagent for clinical diseases, shows potential in the treatment of diabetes and other metabolic diseases. However, it is unknown how NAC modulates the gut microbiota of… Click to show full abstract
N‐Acetylcysteine (NAC), an antioxidative reagent for clinical diseases, shows potential in the treatment of diabetes and other metabolic diseases. However, it is unknown how NAC modulates the gut microbiota of mice with metabolic syndrome. The aim of the present study was to demonstrate the preventive effect of NAC on intestinal dysbiosis and glucose metabolic disorder.
Keywords:
dysbiosis glucose;
acetylcysteine alleviates;
glucose metabolic;
metabolic disorder
Journal Title: Journal of Diabetes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Diabetes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!